Abstract

BackgroundCirculating glycemic traits (GTs) have been considered a risk factor for breast cancer, but studies using GT-associated genetic variants as an instrumental variable are limited and inconclusive.MethodsOur Mendelian Randomization analysis used the most recent genome-wide datasets focusing on European women.ResultsOf 44 single-nucleotide polymorphisms (SNPs) with GTs, 38 fasting-glucose and 6 fasting-insulin SNPs showed heterogeneous associations with breast cancer, without significant directional pleiotropy observed.ConclusionOur findings indicate a null association between genetically determined GTs and breast cancer risk among European women. Our findings may contribute to more complete characterizing of metabolic pathways in GTs and breast cancer.

Highlights

  • Previous studies for circulating glycemic traits (GTs), including fasting glucose (FG) and insulin (FI) concentrations, have shown inconsistent associations with breast cancer development (Gunter et al, 2009; Sieri et al, 2012; Boyle et al, 2013; Hernandez et al, 2014)

  • CI, confidence interval; CGEMS, Cancer Genetic Markers of Susceptibility Breast Cancer Genome-wide Association (GWA) Study; FG, fasting glucose; FI, fasting insulin; GEEA, generalized estimating equation regression adjusted for age; GEEAB, GEEA, adjusted for body mass index; GM, glucose metabolism; Mendelian Randomization (MR), Mendelian randomization; OR, odds ratio; single-nucleotide polymorphisms (SNPs), single–nucleotide polymorphism; T2DM, type 2 diabetes; WHR, waist-to-hip ratio. †Phat was estimated via Cochran’s Q; by correcting multiple comparisons, the MR results for the following sets of SNPs were statistically heterogeneous: FG-OncoArray; FG-OncoArray*; FG-OncoArray-T2DM¥; FG-OncoArray-T2DM¥*; FG-Pooled MR; and FI-OncoArray-WHR¥. *A subset of the GM-SNPs that are statistically associated with breast cancer (p < 0.05) was included in the analysis. ¥GM-SNPs excluding top GWA-SNPs associated with T2DM or WHR were analyzed to reduce the pleiotropic effect from T2DM or WHR, respectively

  • After excluding top GWA-SNPs associated with type 2 diabetes and visceral obesity, the directions of the associations between GTs and breast cancer were changed in OncoArray but not in ATLAS-CGEMS

Read more

Summary

Conclusion

Our findings indicate a null association between genetically determined GTs and breast cancer risk among European women.

INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
DATA AVAILABILITY STATEMENT

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.